selegiline has been researched along with quercetin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Alcaro, S; Bolasco, A; Chimenti, F; Chimenti, P; Cirilli, R; Ferretti, R; Fioravanti, R; Orallo, F; Ortuso, F; Rossi, F; Sanna, ML; Secci, D; Yáñez, M | 1 |
| Oliveri, V | 1 |
| Abu-Serie, MM; Amer, A; Awad, LF; Ayoup, MS; Ragab, HM; Teleb, M | 1 |
| Ali, A; Ali, J; Ashhar, MU; Baboota, S; Qamar, Z; Qizilibash, FF; Sahoo, PK | 1 |
1 review(s) available for selegiline and quercetin
| Article | Year |
|---|---|
Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation.
Topics: alpha-Synuclein; Amyloidogenic Proteins; Drug Discovery; Humans; Protein Aggregation, Pathological; Structure-Activity Relationship | 2019 |
4 other study(ies) available for selegiline and quercetin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors.
Topics: Flavanones; Flavones; Humans; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Stereoisomerism; Sulfhydryl Compounds | 2010 |
Halting colorectal cancer metastasis via novel dual nanomolar MMP-9/MAO-A quinoxaline-based inhibitors; design, synthesis, and evaluation.
Topics: Antineoplastic Agents; Cell Line; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quinoxalines; Structure-Activity Relationship | 2021 |
Lipid nanocarrier of selegiline augmented anti-Parkinson's effect via P-gp modulation using quercetin.
Topics: Animals; Biological Availability; Lipids; Nanoparticles; Particle Size; Quercetin; Rats; Rats, Wistar; Selegiline | 2021 |